Moneycontrol PRO
Loans
HomeNewsAstrazeneca pharma

Astrazeneca Pharma

Jump to
  • Stocks to Watch Today: Lenskart, Cyient, Havells, Lupin, Swiggy, Hindustan Aeronautics, Ashoka Buildcon, Biocon, Nykaa, Kalyan Jewellers in focus on 10 November

    Stocks to Watch, 10 November: Stocks like Bajaj Auto, FSN E-Commerce Ventures Nykaa, Kalyan Jewellers India, JSW Cement,Trent, Global Health, Neuland Laboratories, Ratnamani Metals and Tubes, National Aluminium Company, Force Motors, Torrent Pharmaceuticals, VA Tech Wabag, Olectra Greentech, and Lenskart Solutions will be in focus on November 10.

  • Trade Spotlight: How should you trade RBL Bank, Coromandel International, PI Industries, TD Power, HDFC AMC, Cochin Shipyard and others on July 31?

    Trade Spotlight: How should you trade RBL Bank, Coromandel International, PI Industries, TD Power, HDFC AMC, Cochin Shipyard and others on July 31?

    The consolidation is expected to continue as long as the frontline indices trade below the 50-day EMA. Below are some short-term trading ideas to consider.

  • AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y

    AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y

  • Stocks to Watch Today: Tata Steel, Yes Bank, Godrej Properties, AstraZeneca Pharma, IndusInd Bank, Nykaa, Bajaj Housing Finance in focus on 7 April

    Stocks to Watch Today: Tata Steel, Yes Bank, Godrej Properties, AstraZeneca Pharma, IndusInd Bank, Nykaa, Bajaj Housing Finance in focus on 7 April

    Stocks to Watch, 7 Apr: Stocks like Indian Bank, Tata Motors, ITC, Puravankara, Federal Bank, Bajel Projects, TVS Motor Company, Biocon, Force Motors, Larsen & Toubro, Motilal Oswal Financial Services, and Siemens will be in focus on April 7.

  • Stocks to Watch Today: Lupin, Tata Power, Nazara Tech, Shilpa Medicare, GMR Airports, IRB Infra, Railtel, Shyam Metalics in focus on 10 March

    Stocks to Watch Today: Lupin, Tata Power, Nazara Tech, Shilpa Medicare, GMR Airports, IRB Infra, Railtel, Shyam Metalics in focus on 10 March

    Stocks to Watch, Mar 10: Stocks like India Pesticides, HFCL, NDR Auto Components, JSW Steel, GR Infraprojects, Biocon, Oil and Natural Gas Corporation, Container Corporation of India, Thangamayil Jewellery, Hinduja Global Solutions, IRB Infrastructure Developers, and AstraZeneca Pharma will be in focus on March 10.

  • AstraZeneca Pharma shares gain 3% on CDSCO nod for expanded use of cancer drug Imfinzi

    AstraZeneca Pharma shares gain 3% on CDSCO nod for expanded use of cancer drug Imfinzi

    AstraZeneca Pharma share price: This approval allows the use of Durvalumab in combination with Tremelimumab, broadening treatment options for patients battling advanced-stage liver cancer.

  • AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y

    AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y

  • Stocks to Watch: TVS Motor, IRCTC, Berger Paints, Vodafone Idea, AstraZeneca Pharma

    Stocks to Watch: TVS Motor, IRCTC, Berger Paints, Vodafone Idea, AstraZeneca Pharma

    In this video, we analyze the latest Q3 earnings and key developments from top stocks to watch. TVS Motor has signed an MoU with the Karnataka Government to invest ₹2,000 crore over the next five years. IRCTC reported a 13.7% rise in net profit with a 10% YoY increase in revenue. Berger Paints saw a 1.6% decline in net profit, though revenue rose by 3.2% YoY. Vodafone Idea posted a 1.7% QoQ revenue increase, a 3.6% rise in EBITDA, and an ARPU boost to ₹173 from ₹166. AstraZeneca Pharma delivered stellar results with a 94.9% jump in net profit and a 44% YoY surge in revenue.

  • Stocks to Watch Today: Reliance Industries, Infosys, Axis Bank, LTIMindtree, Havells, HFCL, AstraZeneca, Jubilant Pharmova, Zaggle in focus on 17 January

    Stocks to Watch Today: Reliance Industries, Infosys, Axis Bank, LTIMindtree, Havells, HFCL, AstraZeneca, Jubilant Pharmova, Zaggle in focus on 17 January

    Stocks To Watch, Jan 17: Stocks like Hatsun Agro Products, Metro Brands, Bharat Petroleum Corporation, Mastek, One Mobikwik Systems, Jammu & Kashmir Bank, Satin Creditcare Network, IRCTC, Power Finance Corporation, Suraksha Diagnostic, Indian Bank, TVS Motor Company, and Bajaj Healthcare will be in focus on January 17.

  • AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y

    AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y

  • Stock Radar: Medplus Health, PG Electroplast, Shilpa Medicare, Themis Medicare, Waaree Energies in focus on Tuesday

    Stock Radar: Medplus Health, PG Electroplast, Shilpa Medicare, Themis Medicare, Waaree Energies in focus on Tuesday

    Stocks like Godavari Biorefineries, Gujarat Themis Biosyn, AstraZeneca Pharma, GVK Power and Infrastructure, GMR Airports Infrastructure, and Tilaknagar Industries will also be in focus on November 19.

  • Stock Radar: Eicher Motors, Niva Bupa, Cipla, Zomato, Nykaa, Varun Beverages, Vodafone Idea, NALCO in focus on Thursday

    Stock Radar: Eicher Motors, Niva Bupa, Cipla, Zomato, Nykaa, Varun Beverages, Vodafone Idea, NALCO in focus on Thursday

    Stocks like Rashtriya Chemicals and Fertilizers, Torrent Power, PI Industries, Godrej Industries, Thomas Cook India, AstraZeneca Pharma, Sun TV Network, VRL Logistics, Shilpa Medicare, and KSB will also be in focus on November 14.

  • Stock Radar: ONGC, Reliance, PNB, AstraZeneca, GR Infra, BGR Energy, Arkade Developers, Coal India in focus on Tuesday

    Stock Radar: ONGC, Reliance, PNB, AstraZeneca, GR Infra, BGR Energy, Arkade Developers, Coal India in focus on Tuesday

    Pondy Oxides and Chemicals, Thangamayil Jewellery, Power Grid Corporation of India, Cubex Tubings, G R Infraprojects, Western Carriers India, and Northern Arc Capital will also be in focus on September 24.

  • AstraZeneca Standalone June 2024 Net Sales at Rs 387.52 crore, up 31.16% Y-o-Y

    AstraZeneca Standalone June 2024 Net Sales at Rs 387.52 crore, up 31.16% Y-o-Y

  • AstraZeneca Standalone March 2024 Net Sales at Rs 383.20 crore, up 34.6% Y-o-Y

    AstraZeneca Standalone March 2024 Net Sales at Rs 383.20 crore, up 34.6% Y-o-Y

  • Stock Radar: LIC, Natco Pharma, Lumax Auto Tech, Adani Energy, Concord Biotech, Timken India in focus on Tuesday

    Stock Radar: LIC, Natco Pharma, Lumax Auto Tech, Adani Energy, Concord Biotech, Timken India in focus on Tuesday

    Engineers India, Aditya Birla Fashion and Retail, Amara Raja Energy & Mobility, Aster DM Healthcare, EIH, Exicom Tele-Systems, and IRCTC are among the 440 companies set to announce their March quarter earnings on Tuesday.

  • World Street | US to hike tariffs on Chinese EVs, McDonalds tries to beat inflation, healthcare firms inject $1 bn in France and more

    World Street | US to hike tariffs on Chinese EVs, McDonalds tries to beat inflation, healthcare firms inject $1 bn in France and more

    From Chinese EV tariffs increasing 4x in the USA and Microsoft footing a $242-million bill on infringing copyright law to Apple workers voting to strike in Maryland, here's a look at some of the major developments from across the world.

  • AstraZeneca Pharma rises 4% on getting CDSCO nod to import cancer treatment drug

    AstraZeneca Pharma rises 4% on getting CDSCO nod to import cancer treatment drug

    AstraZeneca Pharma stock has risen 57 percent in the last one year, outperforming benchmark Nifty 50 which has risen 30 percent during the same period.

  • AstraZeneca Standalone December 2023 Net Sales at Rs 305.79 crore, up 22.41% Y-o-Y

    AstraZeneca Standalone December 2023 Net Sales at Rs 305.79 crore, up 22.41% Y-o-Y

  • AstraZeneca Pharma to launch breast cancer drug, shares jump 6%

    AstraZeneca Pharma to launch breast cancer drug, shares jump 6%

    The pharma company will launch Enhertu, a breast cancer drug, in January 2024 in India.

  • AstraZeneca Standalone September 2023 Net Sales at Rs 311.07 crore, up 31.74% Y-o-Y

    AstraZeneca Standalone September 2023 Net Sales at Rs 311.07 crore, up 31.74% Y-o-Y

  • AstraZeneca Standalone June 2023 Net Sales at Rs 295.47 crore, up 27.17% Y-o-Y

    AstraZeneca Standalone June 2023 Net Sales at Rs 295.47 crore, up 27.17% Y-o-Y

  • AstraZeneca Pharma shares gain on pediatric drug launch in India

    AstraZeneca Pharma shares gain on pediatric drug launch in India

    The company already received Import and Market Permission in Form CT-20 from the Drugs Controller General of India.

  • AstraZeneca Standalone December 2022 Net Sales at Rs 249.81 crore, up 24.58% Y-o-Y

    AstraZeneca Standalone December 2022 Net Sales at Rs 249.81 crore, up 24.58% Y-o-Y

  • AstraZeneca Standalone September 2022 Net Sales at Rs 236.13 crore, up 19.43% Y-o-Y

    AstraZeneca Standalone September 2022 Net Sales at Rs 236.13 crore, up 19.43% Y-o-Y

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347